our data indicate that relatively small doses of recombinant alfa-2b interferon given during a 12-week period induce a significant reduction in viral replication and might approximately triple the spontaneous seroconversion rate observed in patients with chronic hepatitis b .
C0021735
recombinant alfa-2b
C0524909
chronic hepatitis b